
IQVIA Holdings IQV
€ 152.78
2.0%
Geschäftsbericht 2025
hinzugefügt 17.02.2026
IQVIA Holdings EV/EBITDA 2011-2026 | IQV
EV/EBITDA Jährlich IQVIA Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.1 | 21.6 | 20.2 | 18.5 | 17.5 | 15.4 | 11.1 | 12.7 | 12.3 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 24.1 | 11.1 | 17 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
27.4 | $ 121.02 | 1.7 % | $ 36.8 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.96 | 4.71 % | $ 96.1 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 22.3 | -5.27 % | $ 234 M | ||
|
Celcuity
CELC
|
-2.38 | $ 111.31 | 3.64 % | $ 4.39 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 28.14 | 2.07 % | $ 782 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 180.97 | 2.92 % | $ 8.97 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 14.14 | 2.56 % | $ 428 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
-4.25 | $ 14.71 | -5.1 % | $ 1.91 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 650.0 | 2.28 % | $ 52.3 B | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Illumina
ILMN
|
70.5 | $ 129.59 | 0.02 % | $ 20.6 B | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.14 | 1.88 % | $ 1.45 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 208.63 | 0.13 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 205.32 | 0.63 % | $ 146 B | ||
|
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.51 | 0.13 % | $ 19.5 B | ||
|
Bioventus
BVS
|
26.4 | $ 8.42 | -3.66 % | $ 527 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 9.65 | -6.26 % | $ 274 M | ||
|
DexCom
DXCM
|
39.5 | $ 73.39 | 0.42 % | $ 28.6 B | ||
|
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 110.81 | 1.94 % | $ 9.14 B | ||
|
Renalytix AI plc
RNLX
|
-32.1 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 19.28 | 2.56 % | $ 1.03 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 281.11 | -0.69 % | $ 23.4 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 77.74 | -1.4 % | $ 5.25 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Guardant Health
GH
|
-28.8 | $ 93.95 | 0.7 % | $ 11.8 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 290.77 | -1.92 % | $ 26.6 B | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 12.53 | 8.11 % | $ 99.4 M | ||
|
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 5.35 | 1.04 % | $ 495 M |